NASDAQ : ESTA
Establishment Labs Holdings Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 68.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.04B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.86B |
| Enterprise Value | 2.06B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 29.80M |
| Shares Outstanding | 29.80M |
| Shares Change (YoY) | +2.27% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 8.50% |
| Owned by Institutions (%) | 79.27% |
| Float | 19.53M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.05 |
| Forward PS | 5.81 |
| PB Ratio | 121.89 |
| P/TBV Ratio | 365.70 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 7.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.57 |
| Quick Ratio | 2.15 |
| Debt / Equity | 17.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.62 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -240.66% |
| Return on Assets (ROA) | -3.11% |
| Return on Invested Capital (ROIC) | -3.86% |
| Return on Capital Employed (ROCE) | -6.04% |
| Weighted Average Cost of Capital (WACC) | 9.85% |
| Revenue Per Employee | $262,977 |
| Profits Per Employee | -$38,301 |
| Employee Count | 1,004 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 0.91 |
Taxes
| Measure | Value |
|---|
| Income Tax | -8.39M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +19.45% |
| 50-Day Moving Average | 67.06 |
| 200-Day Moving Average | 72.38 |
| Relative Strength Index (RSI) | 44.88 |
| Average Volume (20 Days) | 520,281 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.02M |
| Short Previous Month | 3.98M |
| Short % of Shares Out | 13.48% |
| Short % of Float | 20.57% |
| Short Ratio (days to cover) | 10.91 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 264.03M |
| Gross Profit | 185.29M |
| Operating Income | -17.35M |
| Pretax Income | -46.85M |
| Net Income | -38.45M |
| EBITDA | -7.53M |
| EBIT | -17.35M |
| Loss Per Share | -$1.28 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 75.81M |
| Total Debt | 269.53M |
| Net Cash | -193.72M |
| Net Cash Per Share | -$6.50 |
| Equity (Book Value) | 15.59M |
| Book Value Per Share | 0.51 |
| Working Capital | 184.11M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.38M |
| Capital Expenditures | -8.22M |
| Depreciation & Amortization | 9.82M |
| Net Borrowing | 15.13M |
| Free Cash Flow | -21.60M |
| FCF Per Share | -$0.72 |
Margins
| Measure | Value |
|---|
| Gross Margin | 70.18% |
| Operating Margin | -6.57% |
| Pretax Margin | -17.74% |
| Profit Margin | -14.56% |
| EBITDA Margin | -2.85% |
| EBIT Margin | -6.57% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.27% |
| Shareholder Yield | -2.27% |
| Earnings Yield | -2.05% |
| FCF Yield | -1.16% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $98.00 |
| Price Target Difference | 56.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 25.80% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |